Factor This Power Engineering
Live Events
DTECH® Events
POWERGENâ¢
Calendar
Webinars
Podcasts
Contribute Content
Solar
Community
Residential
Utility Scale
Wind Power
Offshore
Turbines & Equipment
Power Grid
Distribution
Grid Modernization
Microgrids
Outage Management
Smart Grids
Transmission
Hydropower
Dams & Civil Structures
Small Hydropower
Technology & Equipment
Tidal & Wave Energy
Energy Storage
Battery
Long Duration
Pumped Storage
Business
Finance
Policy & Regulation
Project Development
Tariffs
Electric Vehicles
EV Charging
Vehicle to Grid
Subscribe
Solar
Community
Residential
Utility Scale
Wind Power
Offshore
Turbines & Equipment
Power Grid
Distribution
Grid Modernization
Microgrids
Outage Management
Transmission
Smart Grids
Hydropower
Dams & Civil Structures
Small Hydro
Technology & Equipment
Tidal & Wave Energy
Energy Storage
Battery
Long Duration
Pumped Storage
Business
Finance
Policy & Regulation
Electric Vehicles
EV Charging
Vehicle to Grid
Factor This: Power Engineering
Live Events
DISTRIBUTECH®
Podcasts
Webinars
Calendar
Contribute Content
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Hydroworld Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Atai Beckley N.V - Common Shares
(NQ:
ATAI
)
4.410
+0.010 (+0.23%)
Streaming Delayed Price
Updated: 10:36 AM EST, Dec 5, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Atai Beckley N.V - Common Shares
< Previous
1
2
...
8
9
10
11
12
13
14
15
16
...
29
30
Next >
Intelgenx Technologies, Cybin Among Top Psychedelic Movers Of Today
↗
January 30, 2023
Via
Benzinga
The "Rags-To-Riches" Portfolio Update: Week Ending January 27
↗
January 29, 2023
The Rags-to-Riches Portfolio tracks the performance of 14 cannabis, psychedelic and plant-based food stocks constituent . Here, performances last week and year-to-date.
Via
Talk Markets
Top 3 Psychedelic Storylines To Watch In 2023
↗
January 29, 2023
This article by James Hallifax was originally published on Microdose and appears here with permission.
Via
Benzinga
Largest Psychedelic Stocks +1.2% This Week; Now +16.1% YTD
↗
January 28, 2023
We track the 6 largest psychedelic stocks that research the treatment of mental illnesses based on the use of one or more psychedelic substances - weekly and YTD results.
Via
Talk Markets
Cybin, GH Research Among Top Psychedelic Movers Of Today
↗
January 27, 2023
Via
Benzinga
This Analyst Still Has Confidence In Atai Life Sciences' Pipeline Despite Recent Setbacks
↗
January 19, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From January 17, 2023
↗
January 17, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From January 11, 2023
↗
January 11, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From January 26, 2023
↗
January 26, 2023
Via
Benzinga
Psychedelic-Derived Medicines for Neurologic Conditions Fueling Large Revenue Growth in Projected $4 Billion Dollar Industry
January 26, 2023
EQNX::TICKER_START (OTCQB:LOBEF),(NASDAQ:ATAI),(NASDAQ:CMPS),(NYSE:CYBN),(NASDAQ:MNMD) EQNX::TICKER_END
Via
FinancialNewsMedia
Topics
Economy
Biomind Labs, Intelgenx Technologies Among Top Psychedelic Movers Of Today
↗
January 25, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From January 10, 2023
↗
January 10, 2023
Via
Benzinga
What 4 Analyst Ratings Have To Say About ATAI Life Sciences
↗
January 09, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From January 24, 2023
↗
January 24, 2023
Via
Benzinga
Atai Life Sciences Investor Christian Angermayer Addresses Recent Trial Results And Pipeline Outlook
↗
January 24, 2023
In our latest Trade To Black Podcast, TDR Founder Shadd Dales and lead financial writer Benjamin A. Smith interview the founder of Apeiron Investment Group, Christian Angermayer.
Via
Benzinga
Psychedelic Stock Gainers And Losers From January 23, 2023
↗
January 23, 2023
Via
Benzinga
"Rags-To-Riches" Portfolio Update: Week Ending January 20, 2023
↗
January 22, 2023
My new portfolio of 14 cannabis, psychedelic and plant-based food stocks were cumulatively pretty awful in 2022, thus could well offer high returns in 2023.
Via
Talk Markets
Largest Psychedelic Stocks +3% This Week; Now +15% YTD
↗
January 21, 2023
Our Psychedelic Drug Stocks Index tracks the six largest psychedelic stocks, by market capitalization, that research the treatment of mental illnesses based on the use of one or more of 10 different...
Via
Talk Markets
Mind Medicine, Seelos Therapeutics Among Top Psychedelic Movers Of Today
↗
January 20, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From January 19, 2023
↗
January 19, 2023
Via
Benzinga
Mind Medicine, Seelos Therapeutics Among Top Psychedelic Movers Of Today
↗
January 18, 2023
Via
Benzinga
Psyched: Psychedelics In Davos, Prince Harry In The 90s, Cathie Wood's Latest Moves And More
↗
January 17, 2023
Psychedelics Take Center Stage In Davos Psychedelics will lead the conversation inside the Davos House of Health for a second year in a row this January.
Via
Benzinga
GH Research, Cybin Among Top Psychedelic Movers Of Today
↗
January 16, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From January 13, 2023
↗
January 13, 2023
Via
Benzinga
Intelgenx Technologies, Cybin Among Top Psychedelic Movers Of Today
↗
January 12, 2023
Via
Benzinga
Cathie Wood Reacts To Atai's Drastic Stock Plunge After Doomed Clinical Study Results
↗
January 12, 2023
After atai Life Sciences (NASDAQ: ATAI) shared the results of subsidiary Perception Neuroscience’s Phase 2 trial of R-ketamine compound for TRD, the psyche
Via
Benzinga
Psychedelic Stock Gainers And Losers From January 9, 2023
↗
January 09, 2023
Via
Benzinga
atai Life Sciences Company GABA Therapeutics Announces Positive Final Results from Phase 1 Single and Multiple Ascending Dose Trial of GRX-917
January 09, 2023
From
atai Life Sciences
Via
GlobeNewswire
My "Rags-To-Riches" Portfolio For 2023: An Introduction
↗
January 08, 2023
The performance of cannabis, psychedelic and plant-based food stocks in 2022 were just horrible; is there any way to go but up?
Via
Talk Markets
atai Life Sciences' Drug Trial For Depression Fails To Deliver Expected Results, Stock Plunges
↗
January 06, 2023
Clinical-stage psychedelics biotech atai Life Sciences (NASDAQ: ATAI) shared the results of its NYC-based subsidiary NYC-based Perception Neuroscience’s Phase 2a study of proprietary R-ketamine PCN-101...
Via
Benzinga
< Previous
1
2
...
8
9
10
11
12
13
14
15
16
...
29
30
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
